Microbio

4128.TWO

0.66 USD

-0.02

-2.94%

Overview

Last close

0.66 usd

Market cap

385.63M usd

52 week high

1.36 usd

52 week low

0.57 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

6.5518

Price/Book Value

1.3504

Enterprise Value

323.24M usd

EV/Revenue

5.4983

EV/EBITDA

-10.9139

Key financials

Revenue TTM

58.79M usd

Gross Profit TTM

23.02M usd

EBITDA TTM

-9.63M usd

Earnings per Share

-0.06 usd

Dividend

N/A usd

Total assets

407.95M usd

Net debt

N/A usd

About

Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. It also involved in the trading of organic foods; sale of beverages; provision of technology development, transfer, and consultation services; and publishing of magazine, as well as offers business consulting services. Microbio Co., Ltd. was incorporated in 2000 and is based in Taipei, Taiwan.